Gonorrhoea of the sigmoid neovagina in a male-to-female transgender

Int J STD AIDS. 2015 Jul;26(8):595-8. doi: 10.1177/0956462414544725. Epub 2014 Jul 23.

Abstract

A 33-year-old male-to-female transgender consulted our outpatient clinic with perneovaginal bleeding during and following coitus. Four years before, she underwent a total laparoscopic sigmoid neovaginoplasty. Physical, histological and endoscopic examination revealed neither focus of active bleeding nor signs of active inflammation. A polymerase chain reaction test performed on a neovaginal swab showed gonococcal infection. Treatment consisted of 500 mg intramuscular ceftriaxone. Three weeks later, our patient reported resolution of symptoms, consistent with eradication of the infection demonstrated by a follow-up neovaginal swab polymerase chain reaction. To our knowledge, this is the first case report of gonococcal infection of the sigmoid neovagina.

Keywords: Gonorrhoea (Neisseria gonorrhoeae); MtF transsexuality; SRS; diagnosis; gender surgery; high-risk behaviour; intestinal neovagina; sexual behaviour; surgery; transgender.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Coitus
  • Colon, Sigmoid / microbiology
  • Colon, Sigmoid / surgery
  • Female
  • Gonorrhea / diagnosis*
  • Gonorrhea / drug therapy
  • Gonorrhea / microbiology
  • Humans
  • Laparoscopy
  • Male
  • Neisseria gonorrhoeae / genetics
  • Neisseria gonorrhoeae / isolation & purification*
  • Polymerase Chain Reaction
  • Transgender Persons*
  • Transsexualism / surgery*
  • Treatment Outcome
  • Uterine Hemorrhage / etiology
  • Vagina
  • Vaginal Diseases / diagnosis*
  • Vaginal Diseases / drug therapy
  • Vaginal Diseases / microbiology

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone